Background Numerous clinical trials have established a role for implantable cardioverter-defibrillators
in the prevention of sudden cardiac death in patients with heart failure. However, …

Femoral and radial artery access continue to be the standard of care for percutaneous
coronary interventions. Cardiac catheterization has progressed to encompass a wide range of …

Background Right ventricular (RV) failure due to pulmonary embolism (PE) increases morbidity
and mortality and contributes to prolonged hospital length of stay and higher costs of care…

Background The effect of significant mitral regurgitation (MR) on outcomes after continuous
flow left ventricular assist device (cfLVAD) implantation remains unclear. Methods We …

Introduction Inotropes are associated with adverse outcomes in heart failure (HF), raising
concern they may accelerate myocardial injury. Whether biomarkers of myocardial necrosis, …

Background Systemic inflammation during implant of a durable left ventricular assist device (LVAD)
may contribute to adverse outcomes. We investigated the association of the …

Introduction: Patients in underdeveloped nations have limited access to life‐saving medical
technology including cardiac rhythm management (CRM) devices. We evaluated alternative …

Objective To assess the in‐hospital and short‐term outcome differences between males
and females who underwent high‐risk PCI with mechanical circulatory support (MCS). …

In patients with severe peripheral vascular disease, the common femoral artery may be so
diseased as to not allow for deployment of mechanical circulatory support (MCS) such as in …

Objective To investigate whether preoperative echocardiography findings determine postoperative
continuous-flow left ventricular assist device outcomes. Methods From January 2003 …